With this extension, IXCHIQ ® , the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory ...

Saint Herblain, France Tuesday, April 1, 2025, 16:00 Hrs [IST] ...

Valneva will provide 40,000 doses of its chikungunya vaccine Ixchiq to French overseas territory La Réunion as part of ...

Valneva responds to French govt’s call for supply of chikungunya vaccine, Ixchiq: Saint Herblain, France Wednesday, March 26, 2025, 17:00 Hrs [IST] Valneva SE, a specialty vacci ...

Valneva has been awarded funding ... The French biotech is the first company to bring a chikungunya vaccine to market, getting FDA approval for its Ixchiq (VLA1553) shot in November 2023 and ...

2 Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ® 3 Valneva Receives Marketing Authorization in Europe for the World's First Chikungunya Vaccine, IXCHIQ® 4 ...

1 Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ® - Valneva 2 Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension ...

Valneva will provide 40,000 doses of its chikungunya vaccine Ixchiq to French overseas territory La Réunion as part of efforts to curb the spike in disease cases on the island. Valneva confirmed ...

Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine ... IXCHIQ ® remains available for purchase in France (mainland and overseas ...

2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is rapidly intensifying in France's Island of ...